Latest Insider Transactions at Broadridge Financial Solutions, Inc. (BR)
This section provides a real-time view of insider transactions for Broadridge Financial Solutions, Inc. (BR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BROADRIDGE FINANCIAL SOLUTIONS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BROADRIDGE FINANCIAL SOLUTIONS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 06
2022
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
34
+0.2%
|
-
|
|
Jul 06
2022
|
Melvin L Flowers Director |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.41%
|
-
|
|
Jul 06
2022
|
Robert N Duelks Director |
BUY
Grant, award, or other acquisition
|
Direct |
76
+0.22%
|
-
|
|
Jul 06
2022
|
Pamela L Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.42%
|
-
|
|
Jul 06
2022
|
Leslie A Brun Director |
BUY
Grant, award, or other acquisition
|
Direct |
109
+0.17%
|
-
|
|
Jun 16
2022
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+2.58%
|
-
|
|
Jun 16
2022
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
250
+1.1%
|
-
|
|
Jun 16
2022
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+17.38%
|
-
|
|
Jun 16
2022
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
190
+4.5%
|
-
|
|
Apr 06
2022
|
Thomas P Carey Corporate VP |
SELL
Payment of exercise price or tax liability
|
Direct |
1,544
-18.69%
|
$245,496
$159.66 P/Share
|
|
Apr 05
2022
|
Leslie A Brun Director |
BUY
Grant, award, or other acquisition
|
Direct |
101
+0.16%
|
-
|
|
Apr 05
2022
|
Pamela L Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.39%
|
-
|
|
Apr 05
2022
|
Robert N Duelks Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+0.21%
|
-
|
|
Apr 05
2022
|
Melvin L Flowers Director |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.2%
|
-
|
|
Apr 05
2022
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
31
+0.19%
|
-
|
|
Apr 05
2022
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
56
+0.13%
|
-
|
|
Apr 05
2022
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.12%
|
-
|
|
Apr 05
2022
|
Thomas J Perna Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+0.14%
|
-
|
|
Apr 05
2022
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.17%
|
-
|
|
Apr 01
2022
|
Richard J Daly Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
5,921
-4.0%
|
$923,676
$156.31 P/Share
|
|
Apr 01
2022
|
Douglas Richard Deschutter Co-President ICS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,022
-3.53%
|
$159,432
$156.31 P/Share
|
|
Apr 01
2022
|
Timothy C Gokey CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,462
-9.78%
|
$2,100,072
$156.31 P/Share
|
|
Apr 01
2022
|
Robert F Kalenka Corporate Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
993
-3.77%
|
$154,908
$156.31 P/Share
|
|
Apr 01
2022
|
Michael Liberatore VP, ICS - Mutual Funds |
SELL
Payment of exercise price or tax liability
|
Direct |
905
-13.01%
|
$141,180
$156.31 P/Share
|
|
Apr 01
2022
|
Laura Matlin CVP, Deputy GC and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
394
-5.54%
|
$61,464
$156.31 P/Share
|
|
Apr 01
2022
|
Vijay Mayadas Corporate Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
671
-2.15%
|
$104,676
$156.31 P/Share
|
|
Apr 01
2022
|
Christopher John Perry President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,006
-3.1%
|
$312,936
$156.31 P/Share
|
|
Apr 01
2022
|
Robert Schifellite Corporate SVP |
SELL
Payment of exercise price or tax liability
|
Direct |
3,077
-5.64%
|
$480,012
$156.31 P/Share
|
|
Apr 01
2022
|
Michael S Tae Corporate VP, CTO, ICS |
SELL
Payment of exercise price or tax liability
|
Direct |
960
-10.65%
|
$149,760
$156.31 P/Share
|
|
Apr 01
2022
|
Richard John Stingi Corporate VP and CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
474
-6.37%
|
$73,944
$156.31 P/Share
|
|
Apr 01
2022
|
Richard John Stingi Corporate VP and CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
432
+10.11%
|
-
|
|
Mar 24
2022
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
184
+2.21%
|
-
|
|
Mar 24
2022
|
Maura A. Markus Director |
BUY
Grant, award, or other acquisition
|
Direct |
209
+0.94%
|
-
|
|
Mar 24
2022
|
Annette L. Nazareth Director |
BUY
Grant, award, or other acquisition
|
Direct |
184
+18.11%
|
-
|
|
Mar 24
2022
|
Amit Zavery Director |
BUY
Grant, award, or other acquisition
|
Direct |
174
+4.35%
|
-
|
|
Feb 16
2022
|
Robert N Duelks Director |
SELL
Open market or private sale
|
Indirect |
1,300
-14.44%
|
$188,500
$145.75 P/Share
|
|
Feb 16
2022
|
Robert N Duelks Director |
SELL
Payment of exercise price or tax liability
|
Direct |
10,465
-12.57%
|
$1,517,425
$145.04 P/Share
|
|
Feb 16
2022
|
Robert N Duelks Director |
BUY
Exercise of conversion of derivative security
|
Direct |
22,056
+22.18%
|
$463,176
$21.98 P/Share
|
|
Feb 15
2022
|
Leslie A Brun Director |
SELL
Payment of exercise price or tax liability
|
Direct |
13,865
-17.92%
|
$2,038,155
$147.06 P/Share
|
|
Feb 15
2022
|
Leslie A Brun Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,899
+19.63%
|
$415,778
$22.67 P/Share
|
|
Feb 04
2022
|
Robert F Kalenka Corporate Vice President |
SELL
Bona fide gift
|
Direct |
350
-1.31%
|
-
|
|
Feb 01
2022
|
Edmund Reese Corporate VP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,075
-21.56%
|
$164,475
$153.33 P/Share
|
|
Feb 01
2022
|
Edmund Reese Corporate VP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,943
+28.04%
|
-
|
|
Jan 31
2022
|
Edmund Reese Corporate VP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,700
-35.83%
|
$270,300
$159.22 P/Share
|
|
Jan 31
2022
|
Edmund Reese Corporate VP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,021
+38.91%
|
-
|
|
Jan 05
2022
|
Leslie A Brun Director |
BUY
Grant, award, or other acquisition
|
Direct |
91
+0.16%
|
-
|
|
Jan 05
2022
|
Pamela L Carter Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.33%
|
-
|
|
Jan 05
2022
|
Robert N Duelks Director |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.2%
|
-
|
|
Jan 05
2022
|
Melvin L Flowers Director |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.21%
|
-
|
|
Jan 05
2022
|
Brett Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
27
+0.17%
|
-
|